Analysis of oxidative stress during the menstrual cycle

Umberto Cornelli, Gianni Belcaro, Maria Rosaria Cesarone, Annarosa Finco, Umberto Cornelli, Gianni Belcaro, Maria Rosaria Cesarone, Annarosa Finco

Abstract

Background: Few data concerning the oxidative stress (OS) in plasma during the entire menstrual cycle of eumenorrheic women are available.

Methods: OS was assessed in 20 healthy volunteers during the phase of the menstrual cycle by determining the plasmatic hydroperoxides levels (d-ROMs test). The assessment was performed every three days, starting from the first day (t1) up the end of the menstrual phase (t27). Concomitantly, the estrogen (E2) and progestin (P4) levels were determined at the same time intervals.

Results: From a base value (t1) of 284 +/- 38.0 CARR.U., which is essentially within the normal range (<300 Carratelli units or CARR.U.), the OS levels progressively increased to 378 +/- 115 CARR.U. at t15, and then slightly decreased over the subsequent time but with average values >300 CARR.U. Analysis of the E2 levels showed that the maximum OS values were noticed near the estrogen peak, while remaining above the base levels, and then decreased during the progestin phase until returning to normal at the end of the menstrual cycle.

Conclusions: It may concludes that the healthy women go into OS for 2/3 of the menstrual cycle.

References

    1. Serviddio G, Loverro G, Vicino M, Prigigallo F, Grattagliano I, Altomare E, Vendemiale G. Modulation of endometrial balance during the menstrual cycle: relation with sex hormones. J Clin Endocrinol Metab. 2002;87:2843–2848. doi: 10.1210/jc.87.6.2843.
    1. Browne RW, Bloom MS, Schisterman EF, Hovey K, Trevisan M, Wu C, Liu A, Wactawski-Wende J. Analytical and biological variation of biomarkers of oxidative stress during the menstrual cycle. Biomarkers. 2008;13:160–183. doi: 10.1080/13547500701775563.
    1. Cornelli U, Belcaro G, Finco A. The oxidative stress balance measured in humans with different markers, following a single oral antioxidants supplementation or a diet poor of antioxidants. J Chem Dermatol Sci Appl. 2011;1:64–70.
    1. Massafra C, Gioia D, De Felice C, Picciolini E, De Leo V, Bonifazi M, Bernabei A. Effects of estrogens and androgens on erythrocyte antioxidant superoxide dismutase, catalase and glutathione peroxidase activities during the menstrual cycle. J Endocrinol. 2000;167:447–452. doi: 10.1677/joe.0.1670447.
    1. Santanam N, Shern-Brewer R, McClatchey R, Castellano PZ, Murphy AA, Voelkel S, Parthasarathy S. Estradiol as an antioxidant: incompatible with its physiological concentrations and function. J Lipid Res. 1998;39:2111–2118.
    1. Cesarone MR, Belcaro G, Carratelli M, Cornelli U, De Sanctis MT, Incandela L, Barsotti A, Terranova R, Nicolaides A. A simple test to monitor oxidative stress. Int Angiol. 1999;18:127–130.
    1. Cornelli U, Terranova R, Luca S, Cornelli M, Alberti A. Bioavailability and antioxidant activity of some food supplements in men and women using the d-ROMs test as a marker of oxidative stress. J Nutr. 2001;131:3208–3211.
    1. Brigelius-Flohè R, Flohé L. Basic principles and emerging concepts in the redox control of transcription factors. Antioxid Redox Signal. 2011;15:2335–2381. doi: 10.1089/ars.2010.3534.
    1. Loose DS, Stancel GM. In: Goodman & Gilman's the pharmacological basis of therapeutics. 11. Brunton LL, Lazo JS, Parker KL, editor. New York: McGraw-Hill; 2006. Estrogens and Progestins; pp. 1541–1571.
    1. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, Huang PL, Jain RK. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Soc Acad Sci USA. 2001;98:2604–2609. doi: 10.1073/pnas.041359198.
    1. Cameron IT, Campbell S. Nitic oxide in the endometrium. Human Repr Update. 1998;4:565–589. doi: 10.1093/humupd/4.5.565.
    1. Foidart JM, De Groote D, Claesen J, Gerday C, Balteau B, Pintiaux A, Perrier d'Hauterive S. Effect of oral contraception with ethiylestradiol and drospirenone on oxidative stress in women 18–35 years old. Contraception. 2009;80:187–193. doi: 10.1016/j.contraception.2009.02.015.
    1. Pincemail J, Vanbelle S, Gaspard U, Collette G, Haleng J, Cheramy-Bien JP, Charlier C, Chapelle JP, Giet D, Albert A. et al.Effect of different contraceptive methods on the oxidative status in women aged 40–48 years from ELAN study in the province of Liège- Belgium. Human Reprod. 2007;22:2335–2343. doi: 10.1093/humrep/dem146.
    1. Sack MN, Rader DJ, O Cannon R. Oestrogens and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet. 1994;343:269–270. doi: 10.1016/S0140-6736(94)91117-7.
    1. Sugioka K, Shimosegawa Y, Nakano M. Estrogerns as natural antioxidants of membrane phospholipid peroxidation. FEBS. 1987;210:37–39. doi: 10.1016/0014-5793(87)81293-0.
    1. Shern-Brewer R, Santanam N, Wetzstein C, White-Welkley J, Parthasarathy S. Exercise and cardiovascular disease a new perspective. Arteriosc Thromb Vasc Biol. 1998;18:1181–1187. doi: 10.1161/01.ATV.18.7.1181.
    1. Chiang K, Parthasarathy S, Santanan N. Estrogen, neutrophils oxidation. Life Sci. 2004;75:2425–2438. doi: 10.1016/j.lfs.2004.04.035.
    1. Swaim MW, Pizzo SV. Methionine sulfoxide and the oxidative regulation of plasma proteinase inhibitors. J Leuk Biol. 1988;43:365–379.
    1. Bani D. Relaxin as a natural agent for vascular health. Vasc Health Risk Manag. 2008;4:515–524.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere